January 21, 2020
Q² Solutions Featured in Pharma Tech Outlook as Among the Top 10 Genomics Solution Providers of 2019
Q² Solutions recognized by Pharma Tech Outlook as a top 10 genomics solution ...December 13, 2019
Q² Solutions Expands Capabilities in Singapore
Q² Solutions announces the expansion of our clinical trial testing operations ...November 27, 2019
Q² Solutions to Expand Genomics Capabilities and Form a Translational Sciences and Innovation Laboratory, Creating 750 New Jobs in North Carolina over the next 10 years
Q² Solutions and the North Carolina Department of Commerce and the Economic ...August 19, 2019
Q² Solutions Welcomes Dr. Bob Bailer as Head of Vaccines Business Unit
Q² Solutions announces the addition of Dr. Bob Bailer as Head of their Vaccines ...June 25, 2019
Q² Solutions, HSBlox and R3 announce successful Proof-of-Concept of blockchain-based solution
Q² Solutions, HSBlox and R3 showcase tracking of human biological samples.May 29, 2019
Q² Solutions Announces Deployment of Next Generation Flow Cytometry Services
Read about Q² Solutions’ Next Generation Flow Cytometry Services deployed in ...April 8, 2019
Q² Solutions | EA Genomics launches Illumina’s TruSight™ Oncology 500 Tumor Profiling assay services for the analysis of Tumor Mutational Burden
Q² Solutions partners with Illumina to launch TruSight™ Oncology 500 Tumor ...March 27, 2019
Q² Solutions Expands Genomics Capabilities in Europe
Q² Solutions Expands Genomics Capabilities in the UK, including Next Generation ...January 23, 2019
Q² Solutions and KingMed Partner to Develop In Vitro Diagnostics and Companion Diagnostics in China
Article about Q² Solutions partnering with KingMed to develop IVD products and ...August 22, 2018
